Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia.

Authors

  • R Siddique Department of Pediatrics Haematology & Oncology, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka,
  • MG Hafiz
  • B Rokeya
  • CY Jamal
  • A Islam

Keywords:

Antiemetics, therapeutic use, Granisetron, Nausea, prevention & control, Ondansetron, Precursor Cell Lymphoblastic Leukemia-Lymphoma, drug therapy, Serotonin Antagonists, Vomiting,

Abstract

Mymensingh Med J. 2011 Oct;20(4):680-8

The abstract of this article is available on the PubMed website

Abstract
234

Published

2012-10-28

How to Cite

Siddique, R., Hafiz, M., Rokeya, B., Jamal, C., & Islam, A. (2012). Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia. Mymensingh Medical Journal, 20(4), 680-688. https://doi.org/10.3329/mmj.v20i4.12415

Issue

Vol. 20 No. 4 (2011)

Section

Original Contributions

How to Cite

Siddique, R., Hafiz, M., Rokeya, B., Jamal, C., & Islam, A. (2012). Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia. Mymensingh Medical Journal, 20(4), 680-688. https://doi.org/10.3329/mmj.v20i4.12415